Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram
Top Cited Papers
- 7 January 2019
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 25 (1) , 70-74
Abstract
Asymptomatic left ventricular dysfunction (ALVD) is present in 3-6% of the general population, is associated with reduced quality of life and longevity, and is treatable when found1-4. An inexpensive, noninvasive screening tool for ALVD in the doctor's office is not available. We tested the hypothesis that application of artificial intelligence (AI) to the electrocardiogram (ECG), a routine method of measuring the heart's electrical activity, could identify ALVD. Using paired 12-lead ECG and echocardiogram data, including the left ventricular ejection fraction (a measure of contractile function), from 44,959 patients at the Mayo Clinic, we trained a convolutional neural network to identify patients with ventricular dysfunction, defined as ejection fraction ≤35%, using the ECG data alone. When tested on an independent set of 52,870 patients, the network model yielded values for the area under the curve, sensitivity, specificity, and accuracy of 0.93, 86.3%, 85.7%, and 85.7%, respectively. In patients without ventricular dysfunction, those with a positive AI screen were at 4 times the risk (hazard ratio, 4.1; 95% confidence interval, 3.3 to 5.0) of developing future ventricular dysfunction compared with those with a negative screen. Application of AI to the ECG-a ubiquitous, low-cost test-permits the ECG to serve as a powerful screening tool in asymptomatic individuals to identify ALVD.Keywords
This publication has 29 references indexed in Scilit:
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization TherapyJACC, 2013
- Three‐Dimensional Echocardiography in Evaluation of Left Ventricular IndicesEchocardiography, 2012
- T-wave morphology abnormalities in benign, potent, and arrhythmogenic Ikr inhibitionHeart Rhythm, 2011
- The Role of N-terminal PRO-Brain Natriuretic Peptide and Echocardiography for Screening Asymptomatic Left Ventricular Dysfunction in a Population at High Risk for Heart Failure. The PROBE-HF StudyJournal of Cardiac Failure, 2009
- Screening for Asymptomatic Left Ventricular Dysfunction Using B‐Type Natriuretic PeptideCongestive Heart Failure, 2008
- Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General CommunityJACC, 2006
- Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic DysfunctionCirculation, 2004
- A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.Circulation, 1981
- The precordial electrocardiogramAmerican Heart Journal, 1944